Cost-Effectiveness Of Midostaurin In The Treatment Of Acute Myeloid Leukemia With The FLT3 Mutation In Spain

Cost-Effectiveness Of Midostaurin In The Treatment Of Acute Myeloid Leukemia With The FLT3 Mutation In Spain

Ainhoa Arenaza,1 Raúl Diez,2 Jordi Esteve,3 Roberta Di Nicolantonio,4 Joana Gostkorzewicz,4 Carlos Martínez,5 Diana Martínez Llinàs,6 Joaquin Martinez-Lopez,7 Pau Montesinos,8 Aída Moure-Fernández,6 Jorge Sierra,9 Joan Lluí...

Full description

Bibliographic Details
Main Authors: Arenaza A, Diez R, Esteve J, Di Nicolantonio R, Gostkorzewicz J, Martínez C, Martínez Llinàs D, Martinez-Lopez J, Montesinos P, Moure-Fernández A, Sierra J, Vinent JL
Format: Article
Language:English
Published: Dove Medical Press 2019-11-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
aml
modeling
efficiency
health economics
economic evaluation.
Online Access:https://www.dovepress.com/cost-effectiveness-of-midostaurin-in-the-treatment-of-acute-myeloid-le-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/cost-effectiveness-of-midostaurin-in-the-treatment-of-acute-myeloid-le-peer-reviewed-article-CEOR

Similar Items